LIBIGEL Trademark

Trademark Overview

On Monday, May 17, 2004, a trademark application was filed for LIBIGEL with the United States Patent and Trademark Office. The USPTO has given the LIBIGEL trademark a serial number of 78420072. The federal status of this trademark filing is CANCELLED - SECTION 8 as of Friday, September 9, 2016. This trademark is owned by BioSante Pharmaceuticals, Inc.. The LIBIGEL trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical products, namely, preparations for the administration of hormones

General Information

Serial Number78420072
Word MarkLIBIGEL
Filing DateMonday, May 17, 2004
Status710 - CANCELLED - SECTION 8
Status DateFriday, September 9, 2016
Registration Number3058248
Registration DateTuesday, February 7, 2006
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 1, 2005

Trademark Statements

Goods and ServicesPharmaceutical products, namely, preparations for the administration of hormones

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code2 - Sec. 8 - Entire Registration
Class Status DateFriday, September 9, 2016
Primary Code005
First Use Anywhere DateMonday, October 7, 2002
First Use In Commerce DateMonday, October 7, 2002

Trademark Owner History

Party NameANI PHARMACEUTICALS, INC.
Party Type31 - New Owner After Registration
Legal Entity Type03 - Corporation
AddressBAUDETTE, MN 56623
Party NameBioSante Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressLincolnshire, IL 60069
Party NameBioSante Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressLincolnshire, IL 60069
Party NameBioSante Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressLincolnshire, IL 60069

Trademark Events

Event DateEvent Description
Friday, September 9, 2016CANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Wednesday, May 25, 2016ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Saturday, February 7, 2015COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Wednesday, January 1, 2014AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Monday, December 23, 2013ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Monday, December 23, 2013TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, August 17, 2012NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Friday, August 17, 2012REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, July 31, 2012REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Friday, August 17, 2012CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Tuesday, July 31, 2012TEAS SECTION 8 & 15 RECEIVED
Tuesday, July 31, 2012TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, February 22, 2007TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, February 7, 2006REGISTERED-PRINCIPAL REGISTER
Thursday, December 29, 2005LAW OFFICE REGISTRATION REVIEW COMPLETED
Friday, December 23, 2005ASSIGNED TO LIE
Thursday, December 22, 2005ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Monday, November 28, 2005STATEMENT OF USE PROCESSING COMPLETE
Friday, November 11, 2005USE AMENDMENT FILED
Friday, November 11, 2005TEAS STATEMENT OF USE RECEIVED
Tuesday, May 24, 2005NOA MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, March 1, 2005PUBLISHED FOR OPPOSITION
Wednesday, February 9, 2005NOTICE OF PUBLICATION
Monday, December 27, 2004LAW OFFICE PUBLICATION REVIEW COMPLETED
Friday, December 17, 2004ASSIGNED TO LIE
Thursday, December 16, 2004APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, December 15, 2004ASSIGNED TO EXAMINER
Monday, May 24, 2004NEW APPLICATION ENTERED IN TRAM

Related Keywords

libigel administration hormones preparations namely products pharmaceutical